Skip to content
Recall Observatory FDA recall evidence

Drug product

Meclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count bottle), Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD, 21801, NDC 59746-122-06

D-0767-2022

March 08, 2022

Class I

Product summary

Firm
Jubilant Cadista Pharmaceuticals, Inc.
Event
Event 89854
Status
Terminated
Classification
Class I
Quantity
12,174 bottles
Official record key
drug-enforcement:D-0767-2022

Official wording

Reason: Labeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled as PredniSONE Tablets. The tablets in the bottles are Meclizine Hydrochloride

Code information: Lot # 22P0036, Exp 12/2024

Distribution pattern: Product was distributed in Arkansas, Florida, North Carolina, South Carolina and Ohio.

Derived failure modes

  • Labeling or packaging

    reason.labeling_packaging · v1.0.0

    Labeling: Label mix-up: Incorrect